Abstract
RECENTLY Evans1 reported the existence of a new pituitary factor, the antagonist, which inhibits follicle development in infantile rats when simultaneously injected with follicle-stimulating extracts from various sources. To avoid misunderstanding, it is proposed to call this factor antifolliculogenic, in contrast with antiluteogenic. At about the same time, Bunde and Greep2 described a regression of persistent corpora lutea in the ovaries of hypophy-sectomized rats by the luteinizing fraction of pituitary extracts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
